← all briefings← 所有簡報

🌅 Pre-Market Briefing盤前簡報 — 2026-06-24 · 11:07 PDT

finviz Elite screen (mktcap ≥ $300M · price ≥ $5 · |gap| ≥ 4%) · catalyst read from full articles · Episodic-Pivot classificationfinviz Elite 篩選(市值 ≥ $300M · 價 ≥ $5 · |漲跌| ≥ 4%) · 讀完整新聞內文判催化 · Episodic Pivot 分類
Up ≥$2B上漲 ≥$2B: 20 · Small-cap小型: 10 · Down下跌: 12
🚀 EP 5 · 🔥 SIP 6
⚠️ Facts + classification only — no buy/sell. Category = catalyst strength (EP > SIP > Bounce). ⚠ notes are a heads-up, not the verdict.只擺事實+分類,不下買賣。分類 = 催化強度(EP > SIP > Bounce)。⚠ 旁註只是提醒,不改分類。

★ MAGNA Top-2massive earnings/sales acceleration + low institutional ownership (screen, confirm catalyst)盈餘/營收爆發加速 + 低法人持股(篩選,需確認催化)

RKT +11.2%
EPS q/q 224.31% · Sales q/q 112.90% · InstOwn 29.57% · $42.4B
Rocket Companies rose with mortgage peers on hopes of a refinancing rebound as rates dipped, not a confirmed company-specific catalyst.Rocket Companies 隨房貸同業因利率回落、再融資回溫的預期而上漲,並非經證實的公司專屬催化劑。

⭐ Watchlist⭐ 觀察清單 always shown永遠列

← swipe →← 左右滑 →
Ticker代號% Chg漲跌%Category分類Catalyst催化
AAPL+0.6%🟡 BounceNo Apple-specific catalyst; coverage centers on Alphabet joining the Dow.無蘋果專屬催化劑;報導集中於 Alphabet 加入道瓊指數。 no Apple-specific catalyst; coverage is about Alphabet joining the Dow無蘋果專屬催化劑;報導重點為 Alphabet 納入道瓊 source新聞
ABBV-0.6%🟡 BounceAbbVie received EU approval for Skyrizi in pediatric plaque psoriasis on a sub-4% move.AbbVie 取得歐盟核准 Skyrizi 用於兒童斑塊型乾癬,但股價變動未達 4%。 EU Skyrizi pediatric approval is incremental; sub-4% move歐盟 Skyrizi 兒科核准屬漸進性利多;漲跌幅未達 4% source新聞
AGI-4.3%🟡 BounceAlamos Gold fell after disclosing seismic events that will reduce 2026 mining rates, prompting a BMO price-target cut.Alamos Gold 揭露將使 2026 年採礦率下降的地震事件後下跌,BMO 因此下調目標價。 seismic events cut 2026 mining rates; BMO price-target cut地震事件導致 2026 年採礦率下降;BMO 下調目標價 source新聞
AMD-1.9%🟡 BounceUBS raised its AMD price target citing CPU demand from agentic AI on a sub-4% move.瑞銀因代理式 AI 帶動 CPU 需求上調 AMD 目標價,但股價變動未達 4%。 UBS price-target raise on CPU demand; sub-4% move瑞銀因 CPU 需求上調目標價;漲跌幅未達 4% source新聞
MU-3.6%🟡 BounceMicron traded ahead of earnings with options pricing a large swing on a sub-4% move.美光在財報前交易,選擇權定價反映大幅波動,但股價變動未達 4%。 pre-earnings positioning; sub-4% move財報前布局;漲跌幅未達 4% source新聞
NVDA-1.2%🟡 BounceNvidia traded slightly lower amid sector news on CoreWeave and an OpenAI-Broadcom chip on a sub-4% move.Nvidia 在 CoreWeave 與 OpenAI-Broadcom 晶片等產業消息下小幅走低,股價變動未達 4%。 sector news (CoreWeave, OpenAI-Broadcom); sub-4% move產業消息(CoreWeave、OpenAI-Broadcom);漲跌幅未達 4% source新聞
PLTR-3.4%🟡 BouncePalantir slipped on a Swiss courtroom loss and European credibility concerns on a sub-4% move.Palantir 因瑞士訴訟敗訴與歐洲信譽疑慮小幅下跌,股價變動未達 4%。 Swiss courtroom loss/credibility headline; sub-4% move瑞士訴訟敗訴/信譽相關標題;漲跌幅未達 4% source新聞
SMCI-3.9%🟡 BounceSuper Micro signed an AI-infrastructure partnership in Turkiye and got an analyst upgrade on a sub-4% move.美超微簽署土耳其 AI 基礎設施合作並獲分析師升評,但股價變動未達 4%。 signed Turkiye AI partnership and an analyst upgrade, but sub-4% move簽署土耳其 AI 合作並獲分析師升評,但漲跌幅未達 4% source新聞

🎯 Gapping Up — Core🎯 盤前上漲 — 核心 ≥ $2B · ≥ 4%, sorted by % change≥ $2B · ≥ 4%,依漲幅排序

← swipe →← 左右滑 →
Ticker代號% Chg漲跌%Category分類Catalyst催化
RUN+18.9%🚀 EPSunrun announced a framework agreement with Tesla and Renew Home to aggregate over 16 GW of residential energy capacity for data centers and utilities.Sunrun 宣布與 Tesla 及 Renew Home 達成框架協議,整合逾 16GW 住宅能源容量供應資料中心與電力公司。 framework agreement (non-binding stage); capacity targets, revenue terms not quantified框架協議(尚未具約束力階段);容量為目標值,營收條款未量化 source新聞
DFTX+17.2%🚀 EPDefinium's Phase 3 trial of an LSD formulation significantly beat placebo in major depression, and it plans a $700M public offering.Definium 一款 LSD 製劑的第三期試驗在重度憂鬱症顯著優於安慰劑,並計劃進行 7 億美元公開募資。 DILUTION: $700M public offering follows the readout稀釋:數據公布後將進行 7 億美元公開募資 source新聞
KBH+16.2%🔥 SIPKB Home's Q2 showed stronger gross margins but weaker orders and homebuyer demand.KB Home 第二季毛利率走強,但訂單與購屋需求轉弱。 margin strength offset by weak orders and demand毛利率強勁但被疲弱訂單與需求抵銷 source新聞
ADPT+14.0%🔥 SIPAdaptive Biotechnologies priced an upsized $300M convertible notes offering and is exploring a separation of its immune-medicine business.Adaptive Biotechnologies 定價擴大後的 3 億美元可轉債,並正評估分拆其免疫醫學業務。 DILUTION: $300M convertible; separation review exploratory, no deal assured稀釋:3 億美元可轉債;分拆檢視屬探索性,未保證成交 source新聞
ICLR+12.5%🔥 SIPICON reported Q1 2026 results with a 2026 outlook, a buyback, and a governance shake-up, amid an ongoing revenue-recognition restatement.ICON 公布 2026 第一季財報並提出 2026 展望、庫藏股與治理改組,同時仍在進行營收認列重編。 revenue-recognition restatement overhang from prior years前幾年營收認列重編的陰影未消 source新聞
RKT+11.2%🟡 BounceRocket Companies rose with mortgage peers on hopes of a refinancing rebound as rates dipped, not a confirmed company-specific catalyst.Rocket Companies 隨房貸同業因利率回落、再融資回溫的預期而上漲,並非經證實的公司專屬催化劑。 rate/refi-driven rebound, not a confirmed company-specific catalyst利率/再融資驅動的反彈,非經證實的公司專屬催化劑 source新聞
MANE+10.9%🟡 BounceVeradermics is presenting at June investor conferences, with analyst price-target commentary and no hard catalyst.Veradermics 將出席 6 月投資人研討會,伴隨分析師目標價評論,無實質催化劑。 investor-conference filler plus analyst price targets, no hard catalyst投資人研討會填充消息加上分析師目標價,無實質催化劑 source新聞
FOUR+10.8% source新聞
NTRA+10.6% source新聞
BLDR+10.4% source新聞
RGEN+10.3% source新聞
MMYT+10.1% source新聞
FND+9.4% source新聞
RH+9.4% source新聞
BKNG+9.0% source新聞
W+9.0% source新聞
MHK+8.7% source新聞
EXPE+8.4% source新聞
TXG+8.4% source新聞
MTH+8.1% source新聞

🚀 Small-Cap Surge🚀 小型衝刺 $300M–$2B · could reach $2B$300M–$2B · 有機會衝 $2B

← swipe →← 左右滑 →
Ticker代號% Chg漲跌%Category分類Catalyst催化
ABSI+37.7%🚀 EPAbsci reported positive interim Phase 1 safety data for ABS-201, its antibody for androgenetic alopecia.Absci 公布其雄性禿抗體 ABS-201 的第一期期中安全數據呈正面結果。 BINARY: early-phase safety data, watch a follow-on raise二元事件:早期安全數據,留意後續增資 source新聞
NVCT+34.5%🚀 EPNuvectis signed an exclusive worldwide license for two Haisco clinical-stage candidates with $40m upfront and up to $1.4bn in milestones.Nuvectis 簽署 Haisco 兩款臨床階段藥物的全球獨家授權,前期款 4000 萬美元、里程碑款最高達 14 億美元。 DILUTION/financing-conditioned: $40m upfront, milestone equity component, financing conditions稀釋/附帶融資條件:4000萬美元前期款,里程碑含股權成分且設有融資條件 source新聞
WEN+30.3%🟡 BounceWendy's surged on a Reddit-driven meme rally citing a new CFO hire and an unconfirmed Trian buyout.溫蒂漢堡在 Reddit 迷因熱潮中飆漲,市場提及新財務長任命與未經證實的 Trian 收購傳聞。 meme-driven; buyout unconfirmed, CFO hire only real news迷因股驅動;收購未經證實,唯一實質消息為新任財務長 source新聞
SLN+22.3%🔥 SIPSilence Therapeutics presented follow-up data at EHA 2026 showing durable efficacy for divesiran in polycythemia vera.Silence Therapeutics 在 2026 EHA 發表追蹤數據,顯示 divesiran 於真性紅血球增多症具持久療效。 conference follow-up data, not a pivotal readout研討會追蹤數據,非關鍵性試驗結果 source新聞
LIFE+20.8%🟡 BounceNo specific catalyst for this LIFE; coverage is valuation-narrative and analyst commentary with conflicting company references.此 LIFE 無具體催化劑;報導為估值敘事與分析師評論,且公司指涉互相矛盾。 headline ambiguous/wrong company; only valuation-narrative commentary標題模糊/指向錯誤公司;僅為估值敘事評論 source新聞
BUUU+16.8%🟡 BounceBUUU Group announced a partial exercise of the underwriters' over-allotment option from its offering.BUUU Group 宣布承銷商部分執行其發行的超額配售選擇權。 over-allotment exercise, no operational catalyst超額配售權執行,無營運催化劑 source新聞
CCXI+16.5%🚀 EPChurchill Capital Corp XI announced a definitive SPAC merger to take humanoid-robot maker Agility Robotics public in a ~$2.5B deal.Churchill Capital Corp XI 宣布確定性 SPAC 合併,將人形機器人公司 Agility Robotics 以約 25 億美元交易帶上市。 de-SPAC merger; [no body] lower confidence; SPAC redemption riskSPAC 合併上市;無正文、信心較低;存在 SPAC 贖回風險 source新聞
DFH+12.8%🟡 BounceDream Finders Homes appointed Clint Szubinski as Chief Operating Officer.Dream Finders Homes 任命 Clint Szubinski 為營運長。 COO appointment, no operational catalyst任命營運長,無營運催化劑 source新聞
FTH+12.4%🟡 BounceFrontier Transport Holdings declared a dividend of ZAR0.277 per share.Frontier Transport Holdings 宣告每股派息 0.277 南非幣。 routine dividend declaration; foreign (JSE) listing例行股利宣告;外國(JSE)掛牌
STTK+12.3%🔥 SIPShattuck Labs priced a $75M public offering.Shattuck Labs 定價 7500 萬美元公開發行。 DILUTION: $75M capital raise稀釋:7500 萬美元增資 source新聞

🔻 Gapping Down🔻 盤前下跌 ≤ -4%≤ -4%

← swipe →← 左右滑 →
Ticker代號% Chg漲跌%Category分類Catalyst催化
RGC-19.4%🟡 BounceRegencell Bioscience changed its independent auditor amid a DOJ investigation, and shares fell.Regencell Bioscience 在司法部調查期間更換獨立簽證會計師,股價下跌。 auditor change plus DOJ investigation overhang更換簽證會計師加上司法部調查陰影 source新聞
CBRS-17.9%🟡 BounceCerebras fell after its first earnings report since its IPO disappointed investors despite an improving outlook.Cerebras 上市後首份財報令投資人失望,儘管展望改善,股價仍下跌。 first post-IPO earnings disappointed despite an improving outlook上市後首份財報令人失望,儘管展望改善 source新聞
NVTS-17.0%🟡 BounceNavitas fell amid a $500M ATM dilution plan following an earlier Nvidia-related run-up.Navitas 在先前因 Nvidia 題材上漲後,因 5 億美元 ATM 稀釋計劃而下跌。 $500M ATM dilution overhang after an earlier run-up先前漲勢後遭 5 億美元 ATM 稀釋陰影壓抑 source新聞
FISN-16.6%🟡 BounceDeep Fission announced a customer pipeline of up to 18.5 GW of potential generation capacity, though shares fell.Deep Fission 宣布最高達 18.5GW 潛在發電容量的客戶管線,但股價下跌。 "up to" pipeline is non-binding; stock fell despite the headline; [no body] lower confidence「最高達」的客戶管線不具約束力;股價逆標題下跌;無正文、信心較低 source新聞
HQ-15.6%🟡 BounceHorizon Quantum pulled back after a large run-up, with valuation and analyst-initiation commentary in focus.Horizon Quantum 在大漲後回落,焦點為估值與分析師起始評等評論。 valuation/analyst-initiation commentary after a huge run-up大幅上漲後的估值與分析師起始評等評論 source新聞
AEVA-15.2%🟡 BounceAeva was selected by Bendix to develop a next-gen active-safety system, but shares fell amid a CEO insider sale.Aeva 獲 Bendix 選為開發次世代主動安全系統,但因執行長內部人賣股,股價下跌。 down despite Bendix design win; CEO insider sale pressured shares儘管獲 Bendix 設計案仍下跌;執行長內部人賣股壓抑股價 source新聞
TMS-15.1%🟡 BounceTMS (Teamshares) began trading on the Nasdaq.TMS(Teamshares)於 Nasdaq 開始交易。 Nasdaq trading debut, post-IPO volatility; [no body] lower confidenceNasdaq 掛牌首日,上市後波動;無正文、信心較低 source新聞
NG-14.5%🟡 BounceNovaGold filed a Q2 report on Donlin Gold progress amid weaker gold prices.NovaGold 在金價走弱之際公布 Donlin Gold 進度的第二季報告。 weaker gold prices; the Q2 report is an incremental project update金價走弱;第二季報告為漸進式專案進度更新 source新聞
CHRN-14.4%🟡 BounceChronoScale appointed a new CTO and CPO, and shares fell amid valuation concerns.ChronoScale 任命新任技術長與產品長,股價在估值疑慮中下跌。 executive appointments; rich-valuation overhang after a big run高階主管任命;大漲後高估值陰影 source新聞
MAAS-14.2%🟡 BounceMaase's subsidiary set up a green-energy infrastructure research team focused on 800VDC technology.Maase 子公司成立綠能基礎設施研究團隊,聚焦 800VDC 技術。 subsidiary R&D announcement; valuation overhang after a sharp surge子公司研發消息;急漲後估值陰影 source新聞
ALOY-13.9% source新聞
AVEX-13.9% source新聞